CIK 0001603454 · Non-accelerated filer<br>Smaller reporting company
Celcuity Inc.
Sign in to watch- Ticker
- CELC
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 763-392-0767
- Business address
- 16305 36TH AVENUE N, SUITE 100, MINNEAPOLIS, MN, 55446
- Former names
- Celcuity LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-10-26 | Cronin Maureen Therese Director | Grant or award | +5,250 | 5,250 | ||
| 2017-10-19 | NIGON RICHARD Director | Grant or award · Stock Option (right to buy) | +8,200 | 8,200 | ||
| 2017-10-19 | Dalvey David Director | Grant or award · Stock Option (right to buy) | +8,200 | 8,200 | ||
| 2017-09-19 | Laing Lance G. Chief Science Officer | Grant or award · Stock Option (right to buy) | +4,110 | 4,110 | ||
| 2017-09-19 | SULLIVAN BRIAN F Chief Executive Officer | Grant or award · Stock Option (right to buy) | +8,220 | 8,220 |
Page 19 of 19 · 365 trades